⌘K

Login Start Free

Home/Filings/4/0001209191-23-029643

4//SEC Filing

Byrnes Michael 4

Accession 0001209191-23-029643

CIK 0001828522other

View on SEC.gov Company Profile

Filed

May 15, 8:00 PM ET

Accepted

May 16, 8:01 AM ET

Size

4.9 KB

Accession

0001209191-23-029643

Insider Transaction Report

Form 4

Period: 2023-05-15

eFFECTOR Therapeutics, Inc.EFTR

Chief Financial Officer

Transactions

Award
Common Stock
2023-05-15$0.46/sh+4,863$2,232→ 38,747 total

Footnotes (1)

[F1]These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

eFFECTOR Therapeutics, Inc.

CIK 0001828522

Entity typeother

Related Parties

1

filerCIK 0001619893

Filing Metadata

Form type: 4
Filed: May 15, 8:00 PM ET
Accepted: May 16, 8:01 AM ET
Size: 4.9 KB

View on SEC.gov